Taking all the factors into consideration, we expect the global thyroid disorder market which was US$1990 million in 2016 to reach US$2400.8 million by 2022, growing with a CAGR of 3.1%.
TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2747 .
MarketResearchFuture.com adds “Thyroid Disorder Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2022” reports to its database.
The intense need for in-depth understanding of the “Thyroid Disorder Market -Forecast to 2022″ coupled with its high growth potential necessitated the development of this report by Market Research Future. The report specifically focuses on the key industry development trends and forces that shapes the market, but not limited to only commercial nature, but which encompasses a broad range such as social, technological and others.
Depending on the geographic region, thyroid disorders market is segmented into four key regions namely America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for thyroid disorders followed by Europe. Asia Pacific region is expected to be fastest growing region in thyroid disorders market due to increasing investments in the healthcare sector, increasing awareness about thyroid disorders, its medication as well as screening.
The report for global thyroid disorder market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the global thyroid market’s segments and regions.
Global Thyroid Disorders Market:
The global thyroid disorders market has been evaluated to be a growing market and it is expected that the market will touch moderate growth figures by growing at a CAGR of 3.1% in future. The major participants of this market are namely Allergan, Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., RLC LABS, AbbVie, Mylan and others.
Thyroid gland produce the hormones namely triiodothyronine (T3) and thyroxine (T4) by trapping iodine from food. These hormones play an important role in the regulation of metabolism, growth & development, intelligence and nervous deficit, fertility, kidney functions, cardiac functions etc. The lack of iodine results in cretinism, goiter, deficient mental development and host of other ailments such as cardiac disorders. According to the international thyroid society almost 20 million Americans suffer from some form of thyroid disease and more than 12 percent of the U.S. population will develop a thyroid condition during their lifetime.
The market driving factors for the world thyroid disorder market are growing prevalence of thyroid disorders, good reimbursement options for treatment and increasing awareness about the implications of thyroid disorders. The rise in screening for iodine disorders and thyroid tumors is also leading to the growth of the market. Growth in risk factors such as obesity, diabetes and auto immune diseases etc. are increasing the number of patients who are suffering from thyroid disorders. For example, diabetics are twice more likely to develop hashimoto’s thyroiditis. Increasing focus of governments especially of developing regions on the healthcare sector and is another driver for the global thyroid disorders market.
The market’s restraints includes high costs of the treatment and side-effects associated with current medication. Thyroid disorders treatment medication have a low therapeutic index which is the difference between safe and effective dose. The rise of alternative medicines has also reduced the market size. The market is an extremely consolidated market with few large players dominating it. The thyroid disorder market also reflects an oligopolistic nature in the drugs and supplements segment with a few molecules such as levothyroxine, cytomel, liothyronine, imidazole and propacil dominating the market.
Global Thyroid Disorder Market has been segmented on the basis of treatment which includes drugs and supplements, diagnostics and surgery. On the basis of disease indication the market is segmented into hypothyroidism, hyperthyroidism and other. On the basis of route of administration the market is segmented into oral, injectable and others. On the basis of end users the market is segmented into hospitals and home use.
Table of Contents:
Chapter 1. Introduction
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
Chapter 2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
Chapter 3. Market Dynamics
3.5 Macroeconomic Indicators
Chapter 4. Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat Of New Entrants
Chapter 5. Global Thyroid Disorders Market, By Treatment
5.2 Drugs And Supplements
AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/2747 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312